A comprehensive view of F. Hoffmann-La Roche Ltd. (Roche). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "METHOD FOR PRODUCING GLYCOPROTEIN COMPOSITIONS"
Published: May 12, 2024 by U.S. Fed News
F. Hoffmann-La Roche Ltd. Advances Gender Equity in Health Leadership and Promotes STEM Education and Sustainable Healthcare
Published: May 10, 2024 by Industry Intelligence Inc.
Roche's Vabysmo sales reach US$927.0M in Q1 2024; Vabysmo poses challenge to Regeneron and Bayer's Eylea HD in the treatment spaces of wet age-related macular degeneration, diabetic macular edema, and macular edema: GlobalData.
Published: May 10, 2024 by ForeignAffairs.co.nz
Enable Injections expands partnership with Roche to develop and commercialize enFuse wearable drug delivery technology; Roche to obtain worldwide exclusive license for specific combinations of the technology
Published: May 09, 2024 by Marketline - Deals
Roche to host virtual event highlighting oncology products and late-stage pipeline assets, open to investors and analysts on May 31
Published: May 08, 2024 by F. Hoffmann-La Roche Ltd. (Roche)

Ask us about our Transformation & Innovation market view

Trending Chart

Interactive chart with headline count